Sodium Content in Hydrochlorothiazide Tablets
Direct Answer
Hydrochlorothiazide (HCTZ) tablets contain negligible amounts of sodium and are safe for patients on low-sodium diets.
Sodium Content Details
Standard HCTZ tablets (12.5 mg, 25 mg, or 50 mg) contain essentially no sodium—the medication itself is a sulfonamide derivative that does not include sodium as part of its chemical structure or typical formulation 1, 2.
The therapeutic mechanism of HCTZ actually promotes sodium excretion by inhibiting sodium-chloride reabsorption in the distal convoluted tubule, making it fundamentally incompatible with adding significant sodium to the formulation 3, 4.
Safety for Low-Sodium Diets
Patients on sodium-restricted diets can safely take HCTZ without concern about the tablet's sodium content 3, 5, 4.
In fact, HCTZ therapy should be combined with dietary sodium restriction (<2 g/day or <5 g salt) to maximize blood pressure reduction—sodium restriction potentiates the efficacy of thiazide diuretics by 5-10 mmHg systolic 6, 3, 5, 7, 4.
Guidelines consistently recommend limiting sodium intake to <2,300 mg/day (<100 mmol/day) for patients with hypertension, diabetes, or chronic kidney disease, and HCTZ does not interfere with achieving this target 5, 8, 9, 5.
Clinical Context: HCTZ and Sodium Restriction
The combination of HCTZ with sodium restriction is more effective than either intervention alone—sodium restriction enhances the blood pressure-lowering effect of thiazide diuretics 3, 5, 7, 4.
Paradoxically, excessive sodium restriction (<50 mmol/day or <1.15 g/day) during HCTZ therapy can cause hyponatremia, hypotension, and overactivation of the renin-angiotensin-aldosterone system, so moderate restriction (80-100 mmol/day or 1.8-2.3 g/day) is preferred 6, 5, 10.
Patients on hemodialysis with sodium restriction (85-100 mmol/day) combined with HCTZ 25 mg once or twice daily achieve excellent blood pressure control with minimal interdialytic weight gain 5.
Important Caveats
While HCTZ tablets themselves contain no meaningful sodium, patients should be counseled that the dietary sodium restriction required for optimal HCTZ efficacy is the critical intervention—not avoidance of the medication 3, 5, 4.
HCTZ at the commonly prescribed doses of 12.5-25 mg daily has inferior 24-hour blood pressure control compared to other antihypertensive classes and lacks outcome data for cardiovascular event reduction, so chlorthalidone (which also contains negligible sodium) is preferred when a thiazide-type diuretic is indicated 3, 1, 2, 11.